1. GM-019 Use of imatinib in GIST and CML: comparison of expenditure between National Cancer Institute of Milan and national expenditure. (24th February 2014) Authors: Festinese, F; Togliardi, E; Brera, F; Di Mauro, C; Lanzo, G; Bifano, F; Saibene, G Journal: European journal of hospital pharmacy Issue: Volume 21(2014)Supplement 1 Page Start: A121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗